Consistent with our previous study, patients with high baseline 18F-FDG tumor uptake had a longer PFS (23); one of the possible reasons is that 17β-estradiol (E2) increases ER-dependent PI3K/Akt activation-mediated Glucose uptake signaling pathway in HR-positive breast cancer cell lines (26). This evidence concerns the gene AKT1 and neoplasm.